BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 17224343)

  • 1. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.
    Kim MS; Sweeney TR; Shigenaga JK; Chui LG; Moser A; Grunfeld C; Feingold KR
    Metabolism; 2007 Feb; 56(2):267-79. PubMed ID: 17224343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines.
    Wang Y; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
    J Lipid Res; 2005 Nov; 46(11):2377-87. PubMed ID: 16106051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response.
    Lu B; Moser AH; Shigenaga JK; Feingold KR; Grunfeld C
    J Lipid Res; 2006 Oct; 47(10):2179-90. PubMed ID: 16847310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivation.
    Røst TH; Haugan Moi LL; Berge K; Staels B; Mellgren G; Berge RK
    Biochim Biophys Acta; 2009 Nov; 1791(11):1076-83. PubMed ID: 19577662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy.
    Sweeney TR; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1313-20. PubMed ID: 16434558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response.
    Feingold K; Kim MS; Shigenaga J; Moser A; Grunfeld C
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E201-7. PubMed ID: 14701665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
    Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
    Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation.
    Lelliott CJ; Ljungberg A; Ahnmark A; William-Olsson L; Ekroos K; Elmgren A; Arnerup G; Shoulders CC; Oscarsson J; Lindén D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2707-13. PubMed ID: 17932310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute phase response is associated with retinoid X receptor repression in rodent liver.
    Beigneux AP; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
    J Biol Chem; 2000 May; 275(21):16390-9. PubMed ID: 10747970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist.
    Buler M; Aatsinki SM; Skoumal R; Komka Z; Tóth M; Kerkelä R; Georgiadi A; Kersten S; Hakkola J
    J Biol Chem; 2012 Jan; 287(3):1847-60. PubMed ID: 22117073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of farnesoid X receptor during the acute phase response.
    Kim MS; Shigenaga J; Moser A; Feingold K; Grunfeld C
    J Biol Chem; 2003 Mar; 278(11):8988-95. PubMed ID: 12519762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC-1α) gene expression and contributes to thermogenic activation of brown fat: involvement of PRDM16.
    Hondares E; Rosell M; Díaz-Delfín J; Olmos Y; Monsalve M; Iglesias R; Villarroya F; Giralt M
    J Biol Chem; 2011 Dec; 286(50):43112-22. PubMed ID: 22033933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells.
    Byun HW; Hong EM; Park SH; Koh DH; Choi MH; Jang HJ; Kae SH; Lee J
    Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):65-73. PubMed ID: 24463082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor gamma, and small heterodimer partner in the transcriptional regulation of glucokinase gene expression in liver.
    Kim TH; Kim H; Park JM; Im SS; Bae JS; Kim MY; Yoon HG; Cha JY; Kim KS; Ahn YH
    J Biol Chem; 2009 May; 284(22):15071-83. PubMed ID: 19366697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
    Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
    Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression.
    Pawar A; Botolin D; Mangelsdorf DJ; Jump DB
    J Biol Chem; 2003 Oct; 278(42):40736-43. PubMed ID: 12917410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fish oil feeding and fasting on LXRalpha/RXRalpha binding to LXRE in the SREBP-1c promoter in mouse liver.
    Nakatani T; Katsumata A; Miura S; Kamei Y; Ezaki O
    Biochim Biophys Acta; 2005 Sep; 1736(1):77-86. PubMed ID: 16112614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.